Results 161 to 170 of about 13,180,974 (307)

Other title: Title from HTML header (viewed Nov. 8, 2010): DAS home page; Connecticut Department of Administrative Services

open access: yes, 2012
Updated irregularly; Title from home page (publisher's Web site, viewed Nov. 8, 2010).; At head of title: State of Connecticut.; "DAS has statutory responsibilities and administrative authority in the areas of personnel recruitment, selection and ...

core  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Other title: Title from HTML header (viewed Nov. 8, 2010): DAS home page; Connecticut Department of Administrative Services

open access: yes, 2014
Updated irregularly; Title from home page (publisher's Web site, viewed Nov. 8, 2010).; At head of title: State of Connecticut.; "DAS has statutory responsibilities and administrative authority in the areas of personnel recruitment, selection and ...

core  

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

open access: yesMolecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Other title: Title from HTML header (viewed Nov. 8, 2010): DAS home page; Connecticut Department of Administrative Services

open access: yes, 2015
Updated irregularly; Title from home page (publisher's Web site, viewed Nov. 8, 2010).; At head of title: State of Connecticut.; "DAS has statutory responsibilities and administrative authority in the areas of personnel recruitment, selection and ...

core  

Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma

open access: yesMolecular Oncology, EarlyView.
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy